Sunshine Biopharma Inc. (SBFMW) stock
SBFMWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SBFM
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/30
$0.03+0.00 (+2.00%)
Close on Oct 30, 2026Market cap $11.36MP/E –Yield –
Sunshine Biopharma operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Sunshine Biopharma's operating cash flow for the twelve months ending Jun 30, 2026 was -$5.35M. For fiscal 2025 it was -$5.33M. The highest annual figure on record is -$297.30K in fiscal 2011.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$5.33M | – |
| FY2024 | Dec 31, 2024 | -$12.52M | – |
| FY2023 | Dec 31, 2023 | -$8.78M | – |
| FY2022 | Dec 31, 2022 | -$5.25M | – |
| FY2021 | Dec 31, 2021 | -$1.83M | – |
| FY2020 | Dec 31, 2020 | -$657.30K | – |
| FY2019 | Dec 31, 2019 | -$495.80K | – |
| FY2018 | Dec 31, 2018 | -$512.81K | – |
| FY2017 | Dec 31, 2017 | -$543.52K | – |
| FY2016 | Dec 31, 2016 | -$314.18K | – |
| FY2015 | Dec 31, 2015 | -$867.64K | – |
| FY2014 | Dec 31, 2014 | -$538.60K | – |
| FY2013 | Dec 31, 2013 | -$564.40K | – |
| FY2012 | Dec 31, 2012 | -$393.05K | – |
| FY2011 | Dec 31, 2011 | -$297.30K | – |
| FY2010 | Dec 31, 2010 | -$348.33K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$917.98K | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.07M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.62M | – |
| Q3 FY2025 | Sep 30, 2025 | -$746.67K | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.27M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.70M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.41M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.36M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.58M | – |
| Q1 FY2024 | Mar 31, 2024 | -$3.19M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.69M | – |
| Q3 FY2023 | Sep 30, 2023 | -$457.29K | – |
| Q2 FY2023 | Jun 30, 2023 | -$3.78M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.85M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.25M | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.12M | – |
| Q2 FY2022 | Jun 30, 2022 | -$573.80K | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.30M | – |
| Q4 FY2021 | Dec 31, 2021 | -$312.11K | – |
| Q3 FY2021 | Sep 30, 2021 | -$600.81K | – |
| Q2 FY2021 | Jun 30, 2021 | -$618.85K | – |
| Q1 FY2021 | Mar 31, 2021 | -$297.36K | – |
| Q4 FY2020 | Dec 31, 2020 | -$423.67K | – |
| Q3 FY2020 | Sep 30, 2020 | -$120.58K | – |
| Q2 FY2020 | Jun 30, 2020 | -$82.02K | – |
| Q1 FY2020 | Mar 31, 2020 | -$31.03K | – |
| Q4 FY2019 | Dec 31, 2019 | -$127.84K | – |
| Q3 FY2019 | Sep 30, 2019 | -$86.54K | – |
| Q2 FY2019 | Jun 30, 2019 | -$47.46K | – |
| Q1 FY2019 | Mar 31, 2019 | -$233.96K | – |
| Q4 FY2018 | Dec 31, 2018 | -$116.05K | – |
| Q3 FY2018 | Sep 30, 2018 | -$170.88K | – |
| Q2 FY2018 | Jun 30, 2018 | -$57.43K | – |
| Q1 FY2018 | Mar 31, 2018 | -$168.46K | – |
| Q4 FY2017 | Dec 31, 2017 | -$209.48K | – |
| Q3 FY2017 | Sep 30, 2017 | -$148.19K | – |
| Q2 FY2017 | Jun 30, 2017 | -$77.81K | – |
| Q1 FY2017 | Mar 31, 2017 | -$108.04K | – |
| Q4 FY2016 | Dec 31, 2016 | -$31.19K | – |
| Q3 FY2016 | Sep 30, 2016 | -$62.99K | – |